medexus pharmaceutic

medexus pharmaceutic

TSX:MDP
Medexus Pharmaceuticals

Chart

Detailed Quote

Medexus Pharmaceuticals Inc, formerly Pediapharm Inc is a leading specialty pharmaceutical company with a strong North American commercial platform. It is focused on the therapeutic areas of auto-immune disease and pediatrics. The leading products are Rasuvo and Metoject, a unique formulation of methotrexate to treat rheumatoid arthritis and other auto-immune diseases; and Rupall, an innovative allergy medication with a unique mode of action.
Featured Articles and Interviews
Canada maple leaves on left and pharmaceutical pills in red and blue on right.

5 Best-performing Canadian Pharma Stocks in 2026

Row of blue-lit test tubes with a blurred purple background.

4 Best-performing Canadian Pharma Stocks (Updated October 2025)

Canada maple leaves on left and pharmaceutical pills in red and blue on right.

5 Best-performing Canadian Pharma Stocks (Updated January 2025)

Press Releases

Medexus Announces Fiscal Year 2026 Results, Demonstrating Continued Momentum and Strong Product-Level Performance of GRAFAPEX for Injection

Medexus Schedules Fourth Fiscal Quarter and Fiscal Year 2026 Conference Call

Medexus Announces License and Supply Deal for UM171 Cell Therapy in Canada

The Conversation (0)